The Adaptive COVID-19 Treatment Trial (ACTT)

Program Manager:

Active Dates:

April 3, 2020 -- April 2, 2025

Awarded Amount:

$40,199,082

Investigator(s):

Awardee Organization:

LEIDOS BIOMEDICAL RESEARCH, INC.
Maryland

Funding ICs:

National Institute of Allergy and Infectious Diseases (NIAID)

Abstract:

To support randomized, controlled clinical trials to evaluate the safety and efficacy of investigational antiviral drugs against COVID-19.